Your browser doesn't support javascript.
loading
Hepatitis of unknown aetiology in children - epidemiological overview of cases reported in Europe, 1 January to 16 June 2022.
Romaní Vidal, Adriana; Vaughan, Aisling; Innocenti, Francesco; Colombe, Soledad; Nerlander, Lina; Rachwal, Natalia; Ciancio, Bruno Christian; Mougkou, Aikaterini; Carvalho, Carlos; Delgado, Enrique; Mook, Piers; de Muylder, Géraldine; Peeters, Michael; Tenev, Tencho; Golkocheva-Markova, Elitsa; Vorobieva Solholm Jensen, Veronika; Koch, Anders; Figoni, Julie; Brouard, Cécile; Nikolopoulou, Georgia; Zisouli, Anastasia; Murphy, Niamh; Broderick, Annemarie; Goldberg, Lital; Rich, Rivka; Hecht Sagie, Lior; Tosti, Maria Elena; Suligoi, Barbara; Joosten, Rosa; Pijnacker, Roan; Fjeldheim, Ingvild; Heen, Eli; Stepien, Malgorzata; Polanski, Piotr; Tato Marinho, Rui; Vieira Martins, João; Varela, Carmen; Avellón, Ana; Andersson, Emmi; Jansson Mörk, Marie; Mandal, Sema; Watson, Conall; Coughlan, Laura; Chand, Meera; Neill, Claire; Bradley, Declan T; Li, Kathy; O'Leary, Maureen; McInnes, Neil; Williams, Christopher J.
Afiliación
  • Romaní Vidal A; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Vaughan A; World Health Organization Regional Office for Europe, Copenhagen, Denmark.
  • Innocenti F; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Colombe S; Epidemiology Unit, Regional Health Agency of Tuscany, Florence, Italy.
  • Nerlander L; World Health Organization Regional Office for Europe, Copenhagen, Denmark.
  • Rachwal N; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Ciancio BC; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Mougkou A; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Carvalho C; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Delgado E; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Mook P; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • de Muylder G; World Health Organization Regional Office for Europe, Copenhagen, Denmark.
  • Peeters M; Sciensano, Epidemiology of Infectious Diseases, Brussels, Belgium.
  • Tenev T; Sciensano, Infectious Diseases in Humans, Viral Diseases, National Reference Centre for Hepatitis Viruses, Brussels, Belgium.
  • Golkocheva-Markova E; National Reference Laboratory Hepatitis viruses, NCIPD-Virology, Sofia, Bulgaria.
  • Vorobieva Solholm Jensen V; National Reference Laboratory Hepatitis viruses, NCIPD-Virology, Sofia, Bulgaria.
  • Koch A; Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
  • Figoni J; Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
  • Brouard C; Santé Publique France, the National Public Health Agency, Saint-Maurice, France.
  • Nikolopoulou G; Santé Publique France, the National Public Health Agency, Saint-Maurice, France.
  • Zisouli A; Greek National Public Health Organization (EODY), Athens, Greece.
  • Murphy N; Greek National Public Health Organization (EODY), Athens, Greece.
  • Broderick A; Health Service Executive HPSC surveillance scientist on the National IMT for hepatitis, Dublin, Ireland.
  • Goldberg L; Children's Health Ireland (CHI), Crumlin, Ireland.
  • Rich R; Israel Ministry of Health, Jerusalem, Israel.
  • Hecht Sagie L; Israel Ministry of Health, Jerusalem, Israel.
  • Tosti ME; Israel Ministry of Health, Jerusalem, Israel.
  • Suligoi B; National Centre for Global Health - Istituto Superiore di Sanità, Rome, Italy.
  • Joosten R; Infectious Disease Department - Istituto Superiore di Sanità, Rome, Italy.
  • Pijnacker R; National Institute for Public Health and the Environment (RIVM), Centre for Infectious Disease Control, Bilthoven, the Netherlands.
  • Fjeldheim I; National Institute for Public Health and the Environment (RIVM), Centre for Infectious Disease Control, Bilthoven, the Netherlands.
  • Heen E; Department of Infection Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway.
  • Stepien M; Department of Infection Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway.
  • Polanski P; Department of Epidemiology of Infectious Diseases and Surveillance, National Institute of Public Health NIH - National Research Institute, Warsaw, Poland.
  • Tato Marinho R; Department of Epidemiology of Infectious Diseases and Surveillance, National Institute of Public Health NIH - National Research Institute, Warsaw, Poland.
  • Vieira Martins J; Gastroenterology and Hepatology Department, Hospital S. Maria; Medical School of Lisbon; National Programme for Viral Hepatitis, Portugal Ministry of Health, Lisbon, Portugal.
  • Varela C; Directorate of Information and Analysis, Directorate-General of Health, Lisbon, Portugal.
  • Avellón A; National Centre of Epidemiology, Carlos III Institute of Health, CIBERESP, Madrid, Spain.
  • Andersson E; National Centre of Microbiology, Carlos III Institute of Health, CIBERESP, Madrid, Spain.
  • Jansson Mörk M; Public Health Agency of Sweden, Solna, Sweden.
  • Mandal S; Public Health Agency of Sweden, Solna, Sweden.
  • Watson C; United Kingdom Health Security Agency Epidemiology Cell, London, United Kingdom.
  • Coughlan L; United Kingdom Health Security Agency Epidemiology Cell, London, United Kingdom.
  • Chand M; United Kingdom Health Security Agency Epidemiology Cell, London, United Kingdom.
  • Neill C; United Kingdom Health Security Agency Incident Director, London, United Kingdom.
  • Bradley DT; Public Health Agency Northern Ireland, Belfast, United Kingdom.
  • Li K; Public Health Agency Northern Ireland, Belfast, United Kingdom.
  • O'Leary M; Regional Virology Laboratory Belfast Health and Social Care Trust, Northern Ireland, Belfast, United Kingdom.
  • McInnes N; Clinical and Protecting Health Directorate, Public Health Scotland, Glasgow, United Kingdom.
  • Williams CJ; West of Scotland Specialist Virology Centre, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom.
Euro Surveill ; 27(31)2022 08.
Article en En | MEDLINE | ID: mdl-35929429
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 / Hepatitis A Límite: Child / Humans País/Región como asunto: Europa Idioma: En Revista: Euro Surveill Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article País de afiliación: Suecia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 / Hepatitis A Límite: Child / Humans País/Región como asunto: Europa Idioma: En Revista: Euro Surveill Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article País de afiliación: Suecia